Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment

Wu Cheng Xian, Toyoaki Murohara, Masafumi Kuzuya, Hideo Izawa, Takeshi Sasaki, Koji Obata, Kohzo Nagata, Takao Nishizawa, Masakazu Kobayashi, Takashi Yamada, Weon Kim, Kohji Sato, Guo Ping Shi, Kenji Okumura, Mitsuhiro Yokota

研究成果: Article

50 引用 (Scopus)

抄録

The elastolytic activity of cathepsins in the myocardium is implicated in hypertensive heart failure (HF). Given that reactive oxygen species are also implicated in protease activation associated with cardiac remodeling, we examined the role of the reactive oxygen species-induced cathepsin activation system in cardiac remodeling during the development of hypertensive HF. Dahl salt-sensitive hypertensive rats maintained on a high-salt diet were treated with vehicle, the cathepsin inhibitor E64d, or the angiotensin receptor blocker olmesartan from 12 to 19 weeks of age. Cathepsin expression and activity were increased in the left ventricle of HF rats; olmesartan inhibited these effects, restored the balance between elastin and collagen in the left ventricle, and suppressed degradation of the elastic lamina of coronary arteries of HF rats. Furthermore, olmesartan inhibited upregulation of NADPH oxidase subunits and activity as well as superoxide generation. These effects of olmesartan were mimicked by E64d and were accompanied by amelioration of cardiac fibrosis. Finally, olmesartan and apocynin reduced angiotensin II-induced increases in cathepsin mRNA and protein levels in cultured rat neonatal cardiac myocytes. These data suggest that cathepsins likely trigger and promote cardiac remodeling and that blocking the angiotensin II type 1 receptor attenuates cathepsin expression and activity by inhibiting the production of superoxide by NADPH oxidase, thereby attenuating cardiac remodeling and dysfunction.

元の言語English
ページ(範囲)358-369
ページ数12
ジャーナルAmerican Journal of Pathology
173
発行部数2
DOI
出版物ステータスPublished - 01-01-2008
外部発表Yes

Fingerprint

Angiotensin II Type 1 Receptor Blockers
Cathepsins
Superoxides
Heart Failure
NADPH Oxidase
Heart Ventricles
Reactive Oxygen Species
Inbred Dahl Rats
Angiotensin Type 1 Receptor
Elastin
Angiotensin Receptor Antagonists
Cardiac Myocytes
Angiotensin II
Coronary Vessels
Myocardium
Fibrosis
Peptide Hydrolases
Up-Regulation
Collagen
Salts

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

これを引用

Xian, Wu Cheng ; Murohara, Toyoaki ; Kuzuya, Masafumi ; Izawa, Hideo ; Sasaki, Takeshi ; Obata, Koji ; Nagata, Kohzo ; Nishizawa, Takao ; Kobayashi, Masakazu ; Yamada, Takashi ; Kim, Weon ; Sato, Kohji ; Shi, Guo Ping ; Okumura, Kenji ; Yokota, Mitsuhiro. / Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment. :: American Journal of Pathology. 2008 ; 巻 173, 番号 2. pp. 358-369.
@article{82b59d5d5f6a4fb4b3e44844cb579070,
title = "Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment",
abstract = "The elastolytic activity of cathepsins in the myocardium is implicated in hypertensive heart failure (HF). Given that reactive oxygen species are also implicated in protease activation associated with cardiac remodeling, we examined the role of the reactive oxygen species-induced cathepsin activation system in cardiac remodeling during the development of hypertensive HF. Dahl salt-sensitive hypertensive rats maintained on a high-salt diet were treated with vehicle, the cathepsin inhibitor E64d, or the angiotensin receptor blocker olmesartan from 12 to 19 weeks of age. Cathepsin expression and activity were increased in the left ventricle of HF rats; olmesartan inhibited these effects, restored the balance between elastin and collagen in the left ventricle, and suppressed degradation of the elastic lamina of coronary arteries of HF rats. Furthermore, olmesartan inhibited upregulation of NADPH oxidase subunits and activity as well as superoxide generation. These effects of olmesartan were mimicked by E64d and were accompanied by amelioration of cardiac fibrosis. Finally, olmesartan and apocynin reduced angiotensin II-induced increases in cathepsin mRNA and protein levels in cultured rat neonatal cardiac myocytes. These data suggest that cathepsins likely trigger and promote cardiac remodeling and that blocking the angiotensin II type 1 receptor attenuates cathepsin expression and activity by inhibiting the production of superoxide by NADPH oxidase, thereby attenuating cardiac remodeling and dysfunction.",
author = "Xian, {Wu Cheng} and Toyoaki Murohara and Masafumi Kuzuya and Hideo Izawa and Takeshi Sasaki and Koji Obata and Kohzo Nagata and Takao Nishizawa and Masakazu Kobayashi and Takashi Yamada and Weon Kim and Kohji Sato and Shi, {Guo Ping} and Kenji Okumura and Mitsuhiro Yokota",
year = "2008",
month = "1",
day = "1",
doi = "10.2353/ajpath.2008.071126",
language = "English",
volume = "173",
pages = "358--369",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

Xian, WC, Murohara, T, Kuzuya, M, Izawa, H, Sasaki, T, Obata, K, Nagata, K, Nishizawa, T, Kobayashi, M, Yamada, T, Kim, W, Sato, K, Shi, GP, Okumura, K & Yokota, M 2008, 'Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment', American Journal of Pathology, 巻. 173, 番号 2, pp. 358-369. https://doi.org/10.2353/ajpath.2008.071126

Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment. / Xian, Wu Cheng; Murohara, Toyoaki; Kuzuya, Masafumi; Izawa, Hideo; Sasaki, Takeshi; Obata, Koji; Nagata, Kohzo; Nishizawa, Takao; Kobayashi, Masakazu; Yamada, Takashi; Kim, Weon; Sato, Kohji; Shi, Guo Ping; Okumura, Kenji; Yokota, Mitsuhiro.

:: American Journal of Pathology, 巻 173, 番号 2, 01.01.2008, p. 358-369.

研究成果: Article

TY - JOUR

T1 - Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment

AU - Xian, Wu Cheng

AU - Murohara, Toyoaki

AU - Kuzuya, Masafumi

AU - Izawa, Hideo

AU - Sasaki, Takeshi

AU - Obata, Koji

AU - Nagata, Kohzo

AU - Nishizawa, Takao

AU - Kobayashi, Masakazu

AU - Yamada, Takashi

AU - Kim, Weon

AU - Sato, Kohji

AU - Shi, Guo Ping

AU - Okumura, Kenji

AU - Yokota, Mitsuhiro

PY - 2008/1/1

Y1 - 2008/1/1

N2 - The elastolytic activity of cathepsins in the myocardium is implicated in hypertensive heart failure (HF). Given that reactive oxygen species are also implicated in protease activation associated with cardiac remodeling, we examined the role of the reactive oxygen species-induced cathepsin activation system in cardiac remodeling during the development of hypertensive HF. Dahl salt-sensitive hypertensive rats maintained on a high-salt diet were treated with vehicle, the cathepsin inhibitor E64d, or the angiotensin receptor blocker olmesartan from 12 to 19 weeks of age. Cathepsin expression and activity were increased in the left ventricle of HF rats; olmesartan inhibited these effects, restored the balance between elastin and collagen in the left ventricle, and suppressed degradation of the elastic lamina of coronary arteries of HF rats. Furthermore, olmesartan inhibited upregulation of NADPH oxidase subunits and activity as well as superoxide generation. These effects of olmesartan were mimicked by E64d and were accompanied by amelioration of cardiac fibrosis. Finally, olmesartan and apocynin reduced angiotensin II-induced increases in cathepsin mRNA and protein levels in cultured rat neonatal cardiac myocytes. These data suggest that cathepsins likely trigger and promote cardiac remodeling and that blocking the angiotensin II type 1 receptor attenuates cathepsin expression and activity by inhibiting the production of superoxide by NADPH oxidase, thereby attenuating cardiac remodeling and dysfunction.

AB - The elastolytic activity of cathepsins in the myocardium is implicated in hypertensive heart failure (HF). Given that reactive oxygen species are also implicated in protease activation associated with cardiac remodeling, we examined the role of the reactive oxygen species-induced cathepsin activation system in cardiac remodeling during the development of hypertensive HF. Dahl salt-sensitive hypertensive rats maintained on a high-salt diet were treated with vehicle, the cathepsin inhibitor E64d, or the angiotensin receptor blocker olmesartan from 12 to 19 weeks of age. Cathepsin expression and activity were increased in the left ventricle of HF rats; olmesartan inhibited these effects, restored the balance between elastin and collagen in the left ventricle, and suppressed degradation of the elastic lamina of coronary arteries of HF rats. Furthermore, olmesartan inhibited upregulation of NADPH oxidase subunits and activity as well as superoxide generation. These effects of olmesartan were mimicked by E64d and were accompanied by amelioration of cardiac fibrosis. Finally, olmesartan and apocynin reduced angiotensin II-induced increases in cathepsin mRNA and protein levels in cultured rat neonatal cardiac myocytes. These data suggest that cathepsins likely trigger and promote cardiac remodeling and that blocking the angiotensin II type 1 receptor attenuates cathepsin expression and activity by inhibiting the production of superoxide by NADPH oxidase, thereby attenuating cardiac remodeling and dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=48749085788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749085788&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2008.071126

DO - 10.2353/ajpath.2008.071126

M3 - Article

C2 - 18583318

AN - SCOPUS:48749085788

VL - 173

SP - 358

EP - 369

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -